Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$29.65 +0.13 (+0.44%)
At close: Sep 30, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (LKFT) Current Deferred Revenue (2013 - 2026)

Updated

Lakefront Biotherapeutics (LKFT) reported Current Deferred Revenue of $37,464 for the quarter ended Mar 31, 2026, down 100.0% from $242.6 million a year earlier but up 0.6% from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) Current Deferred Revenue (2013 - 2026) Analysis & Trends

As of Dec 31, 2025, Lakefront Biotherapeutics posted Current Deferred Revenue of $36,154, down 100.0% from the prior year.

  • Current Deferred Revenue has declined for five consecutive years, with a five-year compound annual growth rate of -96.3% (years ended Dec 2020 to Dec 2025).
  • By year, Current Deferred Revenue came in at $251.62 million in the year ended Dec 31, 2024 (-8.7%), $275.73 million in the year ended Dec 31, 2023 (-99.9%), $385.36 billion in the year ended Dec 31, 2022 (-22.4%) and $496.87 billion in the year ended Dec 31, 2021 (-1.8%).
  • Five-year quarterly Current Deferred Revenue spans a low of $37,249 in the quarter ended Dec 31, 2025 and a high of $480.31 billion in the quarter ended Dec 31, 2021.
  • Year over year, Current Deferred Revenue gained in 1 of the last six quarters, with an average decline of 39.0%.
  • The high point for year-over-year Current Deferred Revenue in five years was the quarter ended Jun 30, 2021 (growth of 13.2%); the low point was the quarter ended Dec 31, 2025 (a decline of 100.0%).
  • Per Business Quant data, the three quarters before the quarter ended Mar 31, 2026 came in at $37,249 (quarter ended Dec 31, 2025), $269.02 million (quarter ended Sep 30, 2025) and $260.62 million (quarter ended Jun 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Lakefront Biotherapeutics 1.95 Bn 1.95 Bn 3.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 37,463.86
Dec 31, 2025 37,249.39
Sep 30, 2025 269.02 Mn
Jun 30, 2025 260.62 Mn
Mar 31, 2025 242.60 Mn
Dec 31, 2024 248.42 Mn
Sep 30, 2024 253.62 Mn
Mar 31, 2024 252.54 Mn
Dec 31, 2023 275.73 Mn
Sep 30, 2023 343.41 Mn
Mar 31, 2023 377.08 Mn
Dec 31, 2022 373.03 Bn
Mar 31, 2022 469.28 Mn
Dec 31, 2021 480.31 Bn
Jun 30, 2021 503.47 Mn
Dec 31, 2020 528.37 Bn
Jun 30, 2020 444.61 Mn
Mar 31, 2020 462.63 Mn
Dec 31, 2019 458.58 Mn
Sep 30, 2019 521.61 Mn
API Access

Lakefront Biotherapeutics Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=LKFT&period=max&api_key=YOUR_API_KEY